4-Nonylphenol-enhanced EZH2 and RNF2 expression, H3K27me3 and H2AK119ub1 marks resulting in silencing of p21CDKN1A in vitro

被引:9
|
作者
Ghosh, Krishna [1 ]
Chatterjee, Biji [1 ]
Maheswari, Uma [2 ]
Athifa, Mariyam [1 ]
Kanade, Santosh R. [1 ,3 ]
机构
[1] Cent Univ Kerala, Dept Biochem & Mol Biol, Sch Biol Sci, Kasaragod 671316, Kerala, India
[2] Pondicherry Univ, Dept Biochem & Mol Biol, Sch Life Sci, Kalapet 605014, Puducherry, India
[3] Univ Hyderabad, Dept Plant Sci, Sch Life Sci, Prof CR Rao Rd, Hyderabad 500046, Telangana, India
关键词
BMI1; CDKN1A/p21/WAF1; E2F-1; endocrine disruptor (EDC); enhancer of zeste homolog 1/2 (EZH1/2); E3 ubiquitin-protein ligase RING1 (RING1A/RING1B); EZH2; H2AK119ub1; H3K27me3; 4-nonylphenol (4-NP); polycomb repressive complex (PRC); RNF2; SP1; suppressor of zeste 12 homolog (SUZ12); SUZ12; ENDOCRINE-DISRUPTING CHEMICALS; EPIGENETIC REGULATION; MOLECULAR-MECHANISMS; CELL-CYCLE; NONYLPHENOL; BINDING; PROTEINS; GROWTH;
D O I
10.2217/epi-2018-0175
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aim: To examine the impact of 4-nonylphenol (4-NP), on the expression of polycomb repressive complexes and cellular proliferation. Materials & methods: Cell proliferation assays, quantitative PCR, Western blotting, luciferase reporter assay, chromatin immunoprecipitation-quantitative PCR were used for the study. Results: The 4-NP at 100 nM concentration significantly increased proliferation of MCF-7 cells. It enhanced the expression of RNF2-BMI1 and EZH2-SUZ12 and concomitantly increased H2AK119ub1 and H3K27me3 repressive marks at p21 proximal promoter resulting in its reduced expression. Selective inhibition of RNF2 or EZH2 reverted the 4-NP action. The phospho-CREB, SP1 and E2F-1 are enriched at proximal promoter of RNF2 and EZH2 and cyclin D1, but not p21. Conclusion: The 4-NP-mediated upregulation of RNF2 and EZH2 resulted in epigenetic silencing of p21.
引用
收藏
页码:899 / 916
页数:18
相关论文
共 50 条
  • [31] 小鼠早期胚胎发育中组蛋白修饰H2AK119ub1与H3K27me3的全基因组解偶联(英文)
    朱业张
    俞佳丽
    戎妍
    吴韵雯
    李阳
    张乐姣
    潘应昊
    范衡宇
    沈立
    Science Bulletin, 2021, 66 (24) : 2489 - 2497
  • [32] Evaluation of H3K27me3 Expression as a Marker of EZH2 Activation in SMARCA4/SMARCA2-Deficient Tumors and Candidate Biomarker for Trials of EZH2 Inhibitors
    Kezlarian, Brie
    Montecalvo, Joseph
    Sauter, Jennifer
    Travis, William
    Gounder, Mrinal
    Rudin, Charles
    Ladanyi, Marc
    Namakydoust, Azadeh
    Rekhtman, Natasha
    LABORATORY INVESTIGATION, 2019, 99
  • [33] Evaluation of H3K27me3 Expression as a Marker of EZH2 Activation in SMARCA4/SMARCA2-Deficient Tumors and Candidate Biomarker for Trials of EZH2 Inhibitors
    Kezlarian, Brie
    Montecalvo, Joseph
    Sauter, Jennifer
    Travis, William
    Gounder, Mrinal
    Rudin, Charles
    Ladanyi, Marc
    Namakydoust, Azadeh
    Rekhtman, Natasha
    MODERN PATHOLOGY, 2019, 32
  • [34] H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
    Hoffmann, Friederike
    Niebel, Dennis
    Aymans, Pia
    Ferring-Schmitt, Sandra
    Dietrich, Dimo
    Landsberg, Jennifer
    CLINICAL EPIGENETICS, 2020, 12 (01)
  • [35] EZH2 -mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma
    Hou, Chen
    Xiao, Lirong
    Ren, Xiang
    Cheng, Lin
    Guo, Bo
    Zhang, Meixia
    Yan, Naihong
    FRONTIERS IN GENETICS, 2022, 13
  • [36] H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
    Hoffmann, F.
    Niebel, D.
    Aymans, P.
    Ferring-Schmitt, S.
    Dietrich, D.
    Landsberg, J.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E111 - E112
  • [37] Mutually exclusive expression of EZH2 and H3K27me3 in non-small cell lung carcinoma
    Onishi, Takafumi
    Takashima, Tsuyoshi
    Kurashige, Masako
    Ohshima, Kenji
    Morii, Eiichi
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 238
  • [38] H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
    Friederike Hoffmann
    Dennis Niebel
    Pia Aymans
    Sandra Ferring-Schmitt
    Dimo Dietrich
    Jennifer Landsberg
    Clinical Epigenetics, 2020, 12
  • [39] The epigenetic EZH2/H3K27me3 axis modulates lactotroph tumor cell proliferation
    Zlocowski, N.
    Sosa, L. d, V
    De la Cruz-Thea, B.
    Guido, C. B.
    Martin, M. G.
    Mukdsi, J. H.
    Torres, A., I
    Petiti, J. P.
    JOURNAL OF ENDOCRINOLOGY, 2023, 257 (02)
  • [40] Evaluation of H3K27me3 and EZH2 in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant GBM
    Venneti, Sriram
    Garimella, Mihir
    Sullivan, Lisa
    Martinez, Daniel
    Huse, Jason
    Heguy, Adriana
    Santi, Mariarita
    Thompson, Craig
    Judkins, Alexander
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (06): : 574 - 574